Mesa Laboratories (MLAB)
(Real Time Quote from BATS)
$129.30 USD
+3.15 (2.50%)
Updated Sep 24, 2024 01:04 PM ET
1-Strong Buy of 5 1
C Value B Growth F Momentum B VGM
Cash flow Statements
Fiscal Year End for Mesa Laboratories, Inc falls in the month of March.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -254.25 | 0.93 | 1.87 | 3.27 | 1.35 |
Depreciation/Amortization & Depletion | 280.00 | 33.82 | 32.53 | 22.62 | 25.10 |
Net Change from Assets/Liabilities | 5.97 | -17.11 | -7.19 | 5.25 | -3.50 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 12.41 | 10.34 | 12.01 | 5.93 | 3.60 |
Net Cash From Operating Activities | 44.13 | 27.98 | 39.22 | 37.07 | 26.56 |
Property & Equipment | -2.57 | -4.54 | -4.43 | -1.99 | -1.48 |
Acquisition/ Disposition of Subsidiaries | -78.74 | -4.95 | -300.79 | 0.00 | -184.10 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -81.31 | -9.49 | -305.23 | -1.99 | -185.59 |
Uses of Funds
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.36 | 7.00 | 7.15 | 150.36 | 89.94 |
Issuance (Repayment) of Debt | 71.00 | -36.00 | 49.00 | 0.00 | 149.50 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -3.45 | -3.41 | -3.34 | -3.17 | -2.72 |
Other Financing Activities | -35.08 | -0.92 | -0.24 | -0.97 | -5.44 |
Net Cash from Financing Activities | 32.84 | -33.33 | 52.58 | 146.23 | 231.28 |
Effect of Exchange Rate Changes | -0.36 | -1.60 | -1.09 | 1.18 | -1.06 |
Net Change In Cash & Equivalents | -4.70 | -16.44 | -214.52 | 182.49 | 71.20 |
Cash at Beginning of Period | 32.91 | 49.35 | 263.87 | 81.38 | 10.19 |
Cash at End of Period | 28.21 | 32.91 | 49.35 | 263.87 | 81.38 |
Diluted Net EPS | -47.20 | 0.17 | 0.35 | 0.64 | 0.31 |
Fiscal Year End for Mesa Laboratories, Inc falls in the month of March.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 3.39 | -254.25 | 0.34 | -1.78 | -0.55 |
Depreciation/Amortization & Depletion | 6.24 | 280.00 | 25.97 | 16.69 | 8.36 |
Net Change from Assets/Liabilities | -0.34 | 5.97 | -2.59 | -2.49 | -1.13 |
Net Cash from Discontinued Operations | 0.00 | NA | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.14 | 12.41 | 7.53 | 7.29 | 3.25 |
Net Cash From Operating Activities | 10.43 | 44.13 | 31.25 | 19.72 | 9.94 |
Property & Equipment | -0.89 | -2.57 | -2.03 | -0.90 | -0.27 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -78.74 | -79.70 | 0.00 | 0.00 |
Investments | 0.00 | NA | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | NA | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.89 | -81.31 | -81.73 | -0.90 | -0.27 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.36 | 0.36 | 0.36 | 0.05 |
Issuance (Repayment) of Debt | -7.22 | 71.00 | 49.00 | -13.00 | -8.00 |
Increase (Decrease) Short-Term Debt | 0.00 | NA | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -0.86 | -3.45 | -2.58 | -1.72 | -0.86 |
Other Financing Activities | -1.02 | -35.08 | -1.01 | -0.71 | -0.71 |
Net Cash from Financing Activities | -9.11 | 32.84 | 45.77 | -15.08 | -9.52 |
Effect of Exchange Rate Changes | -0.18 | -0.36 | 0.03 | -1.03 | -0.68 |
Net Change In Cash & Equivalents | 0.26 | -4.70 | -4.69 | 2.71 | -0.53 |
Cash at Beginning of Period | 28.21 | 32.91 | 32.91 | 32.91 | 32.91 |
Cash at End of Period | 28.47 | 28.21 | 28.22 | 35.62 | 32.38 |
Diluted Net EPS | 0.62 | -47.26 | 0.39 | -0.23 | -0.10 |